Also trades as: GRNAW (NASDAQ) · $vol 0M
GRNA NASDAQ
GreenLight Biosciences Holdings
1W: +0.8%
1M: +2.9%
3M: -8.1%
1Y: -86.8%
$0.30
Last traded 2023-07-21 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$45.4M
52W Range0.177-5.9
Volume143,167
Avg Volume713,367
Beta1.44
Dividend—
Analyst Ratings
Company Info
CEOAndrey Juan Zarur
Employees280
SectorHealthcare
IndustryBiotechnology
IPO Date2022-02-03
Websitegreenlightbiosciences.com
200 Boston Avenue
Medford, MA 02155
US
Medford, MA 02155
US
617 616 8188
About GreenLight Biosciences Holdings
GreenLight Biosciences Holdings is a biotechnology firm focused on developing and commercializing ribonucleic acid (RNA) solutions. Its innovative products serve both the human health and agricultural industries. The company's human health portfolio includes mRNA vaccines and various therapeutic treatments, while its agricultural offerings feature RNA-based innovations designed to protect honeybees and defend crops. Established in 2008, GreenLight Biosciences Holdings is based in Medford, Massachusetts.
Latest News
No recent news
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| COONEY CHARLES L | U-Tender | 305,314 | $0.30 | 2023-07-24 |
| Schlicher Martha | U-Tender | 109,218 | $0.30 | 2023-07-24 |
| Ortega-Valle Marta | J-Other | 105,266 | $0.28 | 2023-07-24 |
| Zarur Juan Andrey | U-Tender | 896,058 | $0.30 | 2023-07-24 |
| Aulisa Lorenzo | J-Other | 2,697 | — | 2023-07-24 |